1. Home
  2. CRNX vs BGM Comparison

CRNX vs BGM Comparison

Compare CRNX & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • BGM
  • Stock Information
  • Founded
  • CRNX 2008
  • BGM 2019
  • Country
  • CRNX United States
  • BGM China
  • Employees
  • CRNX N/A
  • BGM 323
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • BGM
  • Sector
  • CRNX Health Care
  • BGM
  • Exchange
  • CRNX Nasdaq
  • BGM NYSE
  • Market Cap
  • CRNX 2.8B
  • BGM 2.5B
  • IPO Year
  • CRNX 2018
  • BGM 2021
  • Fundamental
  • Price
  • CRNX $30.16
  • BGM $13.30
  • Analyst Decision
  • CRNX Strong Buy
  • BGM
  • Analyst Count
  • CRNX 10
  • BGM 0
  • Target Price
  • CRNX $75.00
  • BGM N/A
  • AVG Volume (30 Days)
  • CRNX 676.7K
  • BGM 78.7K
  • Earning Date
  • CRNX 08-07-2025
  • BGM 08-13-2025
  • Dividend Yield
  • CRNX N/A
  • BGM N/A
  • EPS Growth
  • CRNX N/A
  • BGM N/A
  • EPS
  • CRNX N/A
  • BGM N/A
  • Revenue
  • CRNX $760,000.00
  • BGM $25,097,951.00
  • Revenue This Year
  • CRNX $402.12
  • BGM N/A
  • Revenue Next Year
  • CRNX $770.88
  • BGM N/A
  • P/E Ratio
  • CRNX N/A
  • BGM N/A
  • Revenue Growth
  • CRNX N/A
  • BGM N/A
  • 52 Week Low
  • CRNX $24.10
  • BGM $5.26
  • 52 Week High
  • CRNX $62.53
  • BGM $17.17
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 41.11
  • BGM 50.76
  • Support Level
  • CRNX $32.05
  • BGM $12.55
  • Resistance Level
  • CRNX $31.56
  • BGM $17.17
  • Average True Range (ATR)
  • CRNX 1.08
  • BGM 1.42
  • MACD
  • CRNX -0.18
  • BGM -0.19
  • Stochastic Oscillator
  • CRNX 5.25
  • BGM 32.01

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About BGM QILIAN INTERNATIONAL HLDG GROUP LTD

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Share on Social Networks: